This company listing is no longer active
MPH Aktienübersicht
Master Pharm SA designs and manufactures diet supplements, special nutritional food, dietary products, cosmetics, medical devices, and other consumables in Poland.
Schneeflocken-Punktzahl | |
---|---|
Bewertung | 2/6 |
Künftiges Wachstum | 0/6 |
Vergangene Leistung | 0/6 |
Finanzielle Gesundheit | 5/6 |
Dividenden | 0/6 |
Master Pharm SA Wettbewerber
Preisentwicklung & Leistung
Historische Aktienkurse | |
---|---|
Aktueller Aktienkurs | zł6.05 |
52-Wochen-Hoch | zł6.05 |
52-Wochen-Tief | zł3.85 |
Beta | 0.58 |
11 Monat Veränderung | 0% |
3 Monate Veränderung | 0.83% |
1 Jahr Veränderung | 50.12% |
33 Jahre Veränderung | 8.42% |
5 Jahre Veränderung | 21.98% |
Veränderung seit IPO | -12.32% |
Aktuelle Nachrichten und Updates
Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)
Feb 05Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes
Dec 13Recent updates
Calculating The Intrinsic Value Of Master Pharm SA (WSE:MPH)
Feb 05Returns On Capital At Master Pharm (WSE:MPH) Have Hit The Brakes
Dec 13A Look At The Intrinsic Value Of Master Pharm SA (WSE:MPH)
May 25Master Pharm (WSE:MPH) Will Will Want To Turn Around Its Return Trends
Mar 30Is Master Pharm SA's (WSE:MPH) Latest Stock Performance Being Led By Its Strong Fundamentals?
Mar 02I Ran A Stock Scan For Earnings Growth And Master Pharm (WSE:MPH) Passed With Ease
Feb 04Master Pharm (WSE:MPH) Is Growing Earnings But Are They A Good Guide?
Jan 08Here's What To Make Of Master Pharm's (WSE:MPH) Returns On Capital
Dec 18Master Pharm SA (WSE:MPH) Stock Has Shown Weakness Lately But Financials Look Strong: Should Prospective Shareholders Make The Leap?
Nov 27Aktionärsrenditen
MPH | PL Personal Products | PL Markt | |
---|---|---|---|
7D | 0% | -0.4% | 3.1% |
1Y | 50.1% | 38.0% | 22.8% |
Rendite im Vergleich zur Industrie: MPH exceeded the Polish Personal Products industry which returned -24.9% over the past year.
Rendite vs. Markt: MPH exceeded the Polish Market which returned -30.5% over the past year.
Preisvolatilität
MPH volatility | |
---|---|
MPH Average Weekly Movement | n/a |
Personal Products Industry Average Movement | 4.2% |
Market Average Movement | 5.2% |
10% most volatile stocks in PL Market | 9.1% |
10% least volatile stocks in PL Market | 3.3% |
Stabiler Aktienkurs: MPH has not had significant price volatility in the past 3 months.
Volatilität im Zeitverlauf: Insufficient data to determine MPH's volatility change over the past year.
Über das Unternehmen
Gegründet | Mitarbeiter | CEO | Website |
---|---|---|---|
2002 | n/a | Jacek Franasik | www.masterpharm.pl |
Master Pharm SA's Grundlagenzusammenfassung
MPH grundlegende Statistiken | |
---|---|
Marktanteil | zł119.72m |
Gewinn(TTM) | zł1.68m |
Umsatz(TTM) | zł79.17m |
71.2x
Kurs-Gewinn-Verhältnis1.5x
Kurs-Umsatz-VerhältnisIst MPH zu teuer?
Siehe Fair Value und BewertungsanalyseErträge & Einnahmen
MPH Gewinn- und Verlustrechnung (TTM) | |
---|---|
Einnahmen | zł79.17m |
Kosten der Einnahmen | zł38.67m |
Bruttogewinn | zł40.50m |
Sonstige Ausgaben | zł38.82m |
Umsatz | zł1.68m |
Zuletzt gemeldete Gewinne
Jun 30, 2022
Datum des nächsten Gewinnberichts
Nov 17, 2022
Gewinn per Aktie (EPS) | 0.085 |
Bruttomarge | 51.15% |
Nettogewinnspanne | 2.12% |
Schulden/Eigenkapital-Verhältnis | 16.1% |
Wie hat sich MPH auf lange Sicht entwickelt?
Historische Performance und Vergleiche